← Back to Search

Provider Training + Interactive Texting for HPV Vaccination (Text&Talk Trial)

N/A
Waitlist Available
Led By Stephanie Staras, PhD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must not have
Parents or providers who are unwilling to consent to participation
Adolescents out of the age range for participation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if sending texts or training clinicians can increase HPV vaccination rates for 11-12 year olds in Florida.

Who is the study for?
This trial is for parents of 10- to 12-year-olds who haven't had the HPV vaccine and visit participating Florida clinics. It's also for providers giving primary care to this age group at these clinics. Adolescents outside this age range, those opted-out of texts, or without a cell number on file can't join.
What is being tested?
The study tests two methods to increase HPV vaccination rates: one sends educational text messages to parents, and the other provides brief training to clinicians. The goal is to see if these approaches encourage vaccinations in 11-12 year olds.
What are the potential side effects?
Since the interventions involve education and communication rather than medical treatments, there are no direct side effects from medications or procedures. However, participants may experience an increased volume of communications.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My guardians or I are willing to consent to participation.
Select...
I am not an adolescent.
Select...
I previously chose not to receive text messages.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Initiation of the HPV Vaccine
Up to date for the HPV Vaccine
Secondary study objectives
Frequency of Provider recommendations
Other study objectives
Visited the clinic

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

9Treatment groups
Experimental Treatment
Active Control
Group I: Deferred-clinician training and bundled text messagesExperimental Treatment1 Intervention
Clinicians will receive training after the study and parents will receive bundled text messages.
Group II: Deferred-clinician training and benefits text messagesExperimental Treatment1 Intervention
Clinicians will receive training after the study and parents will receive benefits text messages.
Group III: Bundled clinician training and no text messagesExperimental Treatment1 Intervention
Clinicians will receive bundled approach training and parents will not receive any intervention text messages.
Group IV: Bundled clinician training and bundled text messagesExperimental Treatment2 Interventions
Clinicians will receive bundled approach training and parents will receive bundled text messages.
Group V: Bundled clinician training and benefits text messagesExperimental Treatment2 Interventions
Clinicians will receive bundled approach training and parents will receive benefits text messages.
Group VI: Benefits clinician training and no text messagesExperimental Treatment1 Intervention
Clinicians will receive benefits approach training and parents will not receive any intervention text messages.
Group VII: Benefits clinician training and bundled text messagesExperimental Treatment2 Interventions
Clinicians will receive benefits approach training and parents will receive bundled text messages.
Group VIII: Benefits clinician training and benefits text messagesExperimental Treatment2 Interventions
Clinicians will receive benefits approach training and parents will receive benefits text messages.
Group IX: Deferred-clinician training and no text messagesActive Control1 Intervention
Clinicians will receive training after the study and parents will not receive intervention text messages.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,938 Previous Clinical Trials
41,002,078 Total Patients Enrolled
University of FloridaLead Sponsor
1,403 Previous Clinical Trials
743,253 Total Patients Enrolled
Stephanie Staras, PhDPrincipal InvestigatorUniversity of Florida
4 Previous Clinical Trials
11,664 Total Patients Enrolled

Media Library

Bundled clinician training and no text messages Clinical Trial Eligibility Overview. Trial Name: NCT05006833 — N/A
Human Papillomavirus Research Study Groups: Bundled clinician training and no text messages, Deferred-clinician training and bundled text messages, Benefits clinician training and no text messages, Bundled clinician training and benefits text messages, Benefits clinician training and benefits text messages, Deferred-clinician training and benefits text messages, Bundled clinician training and bundled text messages, Benefits clinician training and bundled text messages, Deferred-clinician training and no text messages
Human Papillomavirus Clinical Trial 2023: Bundled clinician training and no text messages Highlights & Side Effects. Trial Name: NCT05006833 — N/A
Bundled clinician training and no text messages 2023 Treatment Timeline for Medical Study. Trial Name: NCT05006833 — N/A
~1083 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top